|
1
|
Nouhjah S, Shahbazian H, Amoori N,
Jahanfar S, Shahbazian N, Jahanshahi A and Cheraghian B: Postpartum
screening practices, progression to abnormal glucose tolerance and
its related risk factors in Asian women with a known history of
gestational diabetes: A systematic review and meta-analysis.
Diabetes Metab Syndr. 2(Suppl 11): S703–S712. 2017. View Article : Google Scholar
|
|
2
|
Han K, Yao J, Yin X, Zhao M and Sun Q:
Review on the prevalence of diabetes and risk factors and situation
of disease management in floating population in China. Glob Health
Res Policy. 2:332017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu WW, Yang HX, Wang C, Su RN, Feng H and
Kapur A: High prevalence of gestational diabetes mellitus in
beijing: Effect of maternal birth weight and other risk factors.
Chin Med J (Engl). 130:1019–1025. 2017. View Article : Google Scholar
|
|
4
|
Xu Y, Wang L, He J, Bi Y, Li M, Wang T,
Wang L, Jiang Y, Dai M, Lu J, et al: Prevalence and control of
diabetes in Chinese adults. JAMA. 310:948–959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu F, Song R, Feng Y, Guo J, Chen Y,
Zhang Y, Chen T, Wang Y, Huang Y, Li CY, et al: Upregulation of
MG53 induces diabetic cardiomyopathy through transcriptional
activation of peroxisome proliferation-activated receptor α.
Circulation. 131:795–804. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berclaz PY, Gao H, Tobian JA, Swanson DL,
Webb DM, Crapo RO and Jensen RL: The impact of diabetes and age on
pulmonary function: Data from the National Health and Nutrition
Examination Survey. Diabetes Res Clin Pract. 83:e1-e32009.
View Article : Google Scholar
|
|
7
|
Jellis C, Martin J, Narula J and Marwick
TH: Assessment of nonischemic myocardial fibrosis. J Am Coll
Cardiol. 56:89–97. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ares-Carrasco S, Picatoste B,
Benito-Martin A, Zubiri I, Sanz AB, Sanchez-Nino MD, Ortiz A, Egido
J, Tunon J and Lorenzo O: Myocardial fibrosis and apoptosis, but
not inflammation, are present in long-term experimental diabetes.
Am J Physiol Heart Circ Physiol. 297:H2109–H2119. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hollekim-Strand SM, Bjorgaas MR,
Albrektsen G, Tjonna AE, Wisloff U and Ingul CB: High-intensity
interval exercise effectively improves cardiac function in patients
with type 2 diabetes mellitus and diastolic dysfunction: A
randomized controlled trial. J Am Coll Cardiol. 64:1758–1760. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tappia PS, Thliveris J, Xu YJ,
Aroutiounova N and Dhalla NS: Effects of amino acid supplementation
on myocardial cell damage and cardiac function in diabetes. Exp
Clin Cardiol. 16:e17-e222011.
|
|
11
|
Karamitsos TD: Vascular and myocardial
fibrosis in diabetes mellitus. Cardiology. 114:105–106. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lai YL, Aoyama S, Ohata M, Otsuka N,
Shiokawa H, Tomono S, Fujiwara Y, Kanazawa H, Miyoshi N and Ohshima
H: Dysregulation of
dimethylargininedimethylaminohydrolase/asymmetric dimethylarginine
pathway in rat type II diabetic nephropathy. J Clin Biochem Nutr.
51:143–149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sakurada M, Shichiri M, Imamura M, Azuma H
and Hirata Y: Nitric oxide upregulates dimethylarginine
dimethylamino-hydrolase-2 via cyclic GMP induction in endothelial
cells. Hypertension. 52:903–909. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Torondel B, Nandi M, Kelly P,
Wojciak-Stothard B, Fleming I and Leiper J: Adenoviral-mediated
overexpression of DDAH improves vascular tone regulation. Vasc Med.
15:205–213. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng J, Wang K, Jin P, Dong C, Yuan Q, Li
Y and Yang Z: The association of adipose-derived dimethylarginine
dimethylaminohydrolase-2 with insulin sensitivity in experimental
type 2 diabetes mellitus. Acta Biochim Biophys Sin (Shanghai).
45:641–648. 2013. View Article : Google Scholar
|
|
16
|
Thum T, Fraccarollo D, Schultheiss M,
Froese S, Galuppo P, Widder JD, Tsikas D, Ertl G and Bauersachs J:
Endothelial nitric oxide synthase uncoupling impairs endothelial
progenitor cell mobilization and function in diabetes. Diabetes.
56:666–674. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen D, Zhang KQ, Li B, Sun DQ, Zhang H
and Fu Q: Epigallocatechin-3-gallate ameliorates erectile function
in aged rats via regulation of PRMT1/DDAH/ADMA/NOS metabolism
pathway. Asian J Androl. 19:291–297. 2017. View Article : Google Scholar :
|
|
18
|
Wang JH, Chen D, Zhang KQ, Zhang H and Fu
Q: Effect of DDAH/ADMA/NOS regulation pathway on cavernae corporum
cavernosorum rat penis of different age. Andrologia. 48:262–267.
2016. View Article : Google Scholar
|
|
19
|
Yuan Q, Hu CP, Gong ZC, Bai YP, Liu SY, Li
YJ and Jiang JL: Accelerated onset of senescence of endothelial
progenitor cells in patients with type 2 diabetes mellitus: Role of
dimethylarginine dimethylaminohydrolase 2 and asymmetric
dimethylarginine. Biochem Biophys Res Commun. 458:869–876. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu CW, Lin Y, Lei YP, Wang L, He ZM and
Xiong Y: Pyrrolidine dithiocarbamate ameliorates endothelial
dysfunction in thoracic aorta of diabetic rats by preserving
vascular DDAH activity. PLoS One. 12:e01799082017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ayuk SM, Abrahamse H and Houreld NN: The
role of photobiomodulation on gene expression of cell adhesion
molecules in diabetic wounded fibroblasts in vitro. J Photochem
Photobiol B. 161:368–374. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mizamtsidi M, Paschou SA, Grapsa J and
Vryonidou A: Diabetic cardiomyopathy: A clinical entity or a
cluster of molecular heart changes. Eur J Clin Invest. 46:947–953.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang SG, Liu XY, Ye JM, Hu TT, Yang YY,
Han T and Tan W: Isosteviol ameliorates diabetic cardiomyopathy in
rats by inhibiting ERK and NF-κB signaling pathways. J Endocrinol.
238:47–60. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tanaka M, Sydow K, Gunawan F, Jacobi J,
Tsao PS, Robbins RC and Cooke JP: Dimethylarginine
dimethylaminohydrolase overexpression suppresses graft coronary
artery disease. Circulation. 112:1549–1556. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Janssen W, Pullamsetti SS, Cooke J,
Weissmann N, Guenther A and Schermuly RT: The role of
dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary
fibrosis. J Pathol. 229:242–249. 2013. View Article : Google Scholar
|
|
26
|
Pullamsetti SS, Savai R, Dumitrascu R,
Dahal BK, Wilhelm J, Konigshoff M, Zakrzewicz D, Ghofrani HA,
Weissmann N, Eickelberg O, et al: The role of dimethylarginine
dimethylaminohydrolase in idiopathic pulmonary fibrosis. Sci Transl
Med. 3:87ra532011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abhary S, Burdon KP, Kuot A, Javadiyan S,
Whiting MJ, Kasmeridis N, Petrovsky N and Craig JE: Sequence
variation in DDAH1 and DDAH2 genes is strongly and additively
associated with serum ADMA concentrations in individuals with type
2 diabetes. PLoS One. 5:e94622010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Seo HA, Kim SW, Jeon EJ, Jeong JY, Moon
SS, Lee WK, Kim JG, Lee IK and Park KG: Association of the DDAH2
gene polymorphism with type 2 diabetes and hypertension. Diabetes
Res Clin Pract. 98:125–131. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu TM, Lin SJ, Lin MW, Hsu CP and Chung
MY: The association of dimethylarginine dimethylaminohydrolase 1
gene polymorphism with type 2 diabetes: A cohort study. Cardiovasc
Diabetol. 10:162011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu CW, Guo Z, Feng M, Wu ZZ, He ZM and
Xiong Y: Ex vivo gene transferring of human dimethylarginine
dimethylaminohy-drolase-2 improved endothelial dysfunction in
diabetic rat aortas and high glucose-treated endothelial cells.
Atherosclerosis. 209:66–73. 2010. View Article : Google Scholar
|
|
31
|
Rajan N, Habermehl J, Coté MF, Doillon CJ
and Mantovani D: Preparation of ready-to-use, storable and
reconstituted type I collagen from rat tail tendon for tissue
engineering applications. Nat Protoc. 1:2753–2758. 2006. View Article : Google Scholar
|
|
32
|
Challa AA, Vukmirovic M, Blackmon J and
Stefanovic B: Withaferin-A reduces type I collagen expression in
vitro and inhibits development of myocardial fibrosis in vivo. PLoS
One. 7:e429892012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Querejeta R, López B, González A, Sánchez
E, Larman M, Martínez Ubago JL and Díez J: Increased collagen type
I synthesis in patients with heart failure of hypertensive origin:
Relation to myocardial fibrosis. Circulation. 110:1263–1268. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yucel T, Mutnal A, Fay K, Fligiel SE, Wang
T, Johnson T, Baker SR and Varani J: Matrix metalloproteinase
expression in basal cell carcinoma: Relationship between enzyme
profile and collagen fragmentation pattern. Exp Mol Pathol.
79:151–160. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu X, Atzler D, Xu X, Zhang P, Guo H, Lu
Z, Fassett J, Schwedhelm E, Böger RH, Bache RJ and Chen Y:
Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme
for degrading the cardiovascular risk factor asymmetrical
dimethylarginine. Arterioscler Thromb Vasc Biol. 31:1540–1546.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ko CH, Shen SC, Lee TJ and Chen YC:
Myricetin inhibits matrix metalloproteinase 2 protein expression
and enzyme activity in colorectal carcinoma cells. Mol Cancer Ther.
4:281–290. 2005.PubMed/NCBI
|
|
37
|
Hasegawa K, Wakino S, Tanaka T, Kimoto M,
Tatematsu S, Kanda T, Yoshioka K, Homma K, Sugano N, Kurabayashi M,
et al: Dimethylarginine dimethylaminohydrolase 2 increases vascular
endothelial growth factor expression through Sp1 transcription
factor in endothelial cells. Arterioscler Thromb Vasc Biol.
26:1488–1494. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lewandowski KC, Banach E, Bieńkiewicz M
and Lewiński A: Matrix metalloproteinases in type 2 diabetes and
non-diabetic controls: Effects of short-term and chronic
hyperglycaemia. Arch Med Sci. 7:294–303. 2011. View Article : Google Scholar
|
|
39
|
Van Linthout S, Seeland U, Riad A,
Eckhardt O, Hohl M, Dhayat N, Richter U, Fischer JW, Böhm M,
Pauschinger M, et al: Reduced MMP-2 activity contributes to cardiac
fibrosis in experimental diabetic cardiomyopathy. Basic Res
Cardiol. 103:319–327. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu J, van Mil A, Aguor EN, Siddiqi S,
Vrijsen K, Jaksani S, Metz C, Zhao J, Strijkers GJ, Doevendans PA
and Sluijter JP: MiR-155 inhibits cell migration of human
cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP-16. J
Cell Mol Med. 16:2379–2386. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Peterson NB, Beeghly-Fadiel A, Gao YT,
Long J, Cai Q, Shu XO and Zheng W: Polymorphisms in tissue
inhibitors of metalloproteinases-2 and -3 and breast cancer
susceptibility and survival. Int J Cancer. 125:844–850. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Miyoshi H, Kanekura T, Aoki T and Kanzaki
T: Beneficial effects of tissue inhibitor of metalloproteinases-2
(TIMP-2) on chronic dermatitis. J Dermatol. 32:346–353. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhou R, Ma P, Xiong A, Xu Y, Wang Y and Xu
Q: Protective effects of low-dose rosuvastatin on
isoproterenol-induced chronic heart failure in rats by regulation
of DDAH-ADMA-NO pathway. Cardiovasc Ther. 35:2017. View Article : Google Scholar
|
|
44
|
Frombaum M, Therond P, Djelidi R, Beaudeux
JL, Bonnefont-Rousselot D and Borderie D: Piceatannol is more
effective than resveratrol in restoring endothelial cell
dimethylarginine dimethylaminohydrolase expression and activity
after high-glucose oxidative stress. Free Radic Res. 45:293–302.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Novella S, Laguna-Fernández A,
Lázaro-Franco M, Sobrino A, Bueno-Betí C, Tarín JJ, Monsalve E,
Sanchís J and Hermenegildo C: Estradiol, acting through estrogen
receptor alpha, restores dimethylarginine dimethylaminohydrolase
activity and nitric oxide production in oxLDL-treated human
arterial endothelial cells. Mol Cell Endocrinol. 365:11–16. 2013.
View Article : Google Scholar
|
|
46
|
Pope AJ, Karuppiah K and Cardounel AJ:
Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial
nitric oxide production. Pharmacol Res. 60:461–465. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jiang DJ, Jia SJ, Yan J, Zhou Z, Yuan Q
and Li YJ: Involvement of DDAH/ADMA/NOS pathway in nicotine-induced
endothelial dysfunction. Biochem Biophys Res Commun. 349:683–693.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Palm F, Onozato ML, Luo Z and Wilcox CS:
Dimethylarginine dimethylaminohydrolase (DDAH): Expression,
regulation, and function in the cardiovascular and renal systems.
Am J Physiol Heart Circ Physiol. 293:H3227–H3245. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jiang DJ, Jia SJ, Dai Z and Li YJ:
Asymmetric dimethylarginine induces apoptosis via p38
MAPK/caspase-3-dependent signaling pathway in endothelial cells. J
Mol Cell Cardiol. 40:529–539. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Greco R, Ferrigno A, Demartini C, Zanaboni
A, Mangione AS, Blandini F, Nappi G, Vairetti M and Tassorelli C:
Evaluation of ADMA-DDAH-NOS axis in specific brain areas following
nitroglycerin administration: Study in an animal model of migraine.
J Headache Pain. 16:5602015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
King DE, Player M and Everett CJ: The
impact of pioglitazone on ADMA and oxidative stress markers in
patients with type 2 diabetes. Prim Care Diabetes. 6:157–161. 2012.
View Article : Google Scholar
|
|
52
|
Kazakov A, Hall R, Jagoda P, Bachelier K,
Müller-Best P, Semenov A, Lammert F, Böhm M and Laufs U: Inhibition
of endothelial nitric oxide synthase induces and enhances
myocardial fibrosis. Cardiovasc Res. 100:211–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yuan Q, Peng J, Liu SY, Wang CJ, Xiang DX,
Xiong XM, Hu CP and Li YJ: Inhibitory effect of resveratrol
derivative BTM-0512 on high glucose-induced cell senescence
involves dimethylaminohydrolase/asymmetric dimethylarginine
pathway. Clin Exp Pharmacol Physiol. 37:630–635. 2010. View Article : Google Scholar : PubMed/NCBI
|
